Researchers at Vanderbilt University Medical Center played a key role in the development of remdesivir, the first drug approved by the U.S. Food and Drug Administration for the treatment of COVID-19.

Despite a decrease in the volume of cars on the road during the COVID-19 pandemic, the National Highway Traffic Safety Administration (NHTSA) reports that driving patterns and behaviors were riskier, leading to an increase in accident-related fatalities since April 2020.